Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 331303Generated: October 30, 2026

(Pyrimidin-5-yl)boronic acid → 3-(4-chlorophenyl)-6-(2-(4-(methylsulfonyl)piperazin-1-yl)ethoxy)-2-(pyrimidin-5-yl)-1H-inden-1-one

https://huagongshe.com/reaction/331303

Reaction equation

Participants

RoleNameHCIDCharge
Reactant(Pyrimidin-5-yl)boronic acidHCID 2795193—
Reactant6-(2-morpholinoethoxy)-2-bromo-3-phenyl-1H-inden-1-oneHCID 70307620—
Reactant2-Bromo-3-(4-chlorophenyl)-6-(2-(4-(methylsulfonyl)piperazin-1-yl)ethoxy)-1H-inden-1-oneHCID 70314438—
Product3-(4-chlorophenyl)-6-(2-(4-(methylsulfonyl)piperazin-1-yl)ethoxy)-2-(pyrimidin-5-yl)-1H-inden-1-oneHCID 5100183350%

Reaction Steps

The procedure of Step 7 of Example 1 was repeated except for using 2-bromo-3-(4-chlorophenyl)-6-(2-(4-(methylsulfonyl)piperazin-1-yl)ethoxy)-1H-inden-1-one obtained in Step 1 of Example 53 as a starting material instead of 6-(2-morpholinoethoxy)-2-bromo-3-phenyl-1H-inden-1-one, 5-pyrimidinylboronic acid instead of 3-pyridinylboronic acid, and being purified by prep HPLC (CH3CN/H2O=7:3) to obtain the title compound (50%).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08877747B2
Source datasetuspto-grants-2014_11
ORD IDord-585d45f728b64271a643af50b32223e0
Source noteuspto-grants-2014_11